<DOC>
	<DOCNO>NCT01116440</DOCNO>
	<brief_summary>The purpose study determine efficacy , safety , tolerability pharmacokinetics multiple dos BGS649 concurrent daily administration combine oral contraception patient refractory endometriosis</brief_summary>
	<brief_title>A Safety &amp; Efficacy Study BGS649 Women With Refractory Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<criteria>Must surgical diagnosis endometriosis est . w/in 5 year screen . Subjects must self report moderate severe pelvic pain screening confirm runinphase Subjects moderate severe pelvic pain refractory surgery ( persistent recurrent pelvic pain within 24 month therapeutic surgery ) least two hormonal therapy two different class , include one approve hormonal therapy Subjects undergone hysterectomy bilateral oophorectomy . Surgical treatment endometriosis within 3 month screen . Subjects pregnant pregnant within 3 month visit one . Subjects nurse lactate Subjects tobacco smoker . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Menstrual pain</keyword>
	<keyword>Refractory endometriosis</keyword>
	<keyword>Pelvic pain</keyword>
</DOC>